申请人:Allergan, Inc.
公开号:US07960381B2
公开(公告)日:2011-06-14
A compound comprising or a pharmaceutically acceptable salt, prodrug, or a metabolite thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.
本文披露了一种包括药学上可接受的盐、前药或其代谢物的化合物。其中,Y、A和B的描述如本文所述。本文还披露了与这些化合物相关的方法、组合物和药物。